Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Pazzi is active.

Publication


Featured researches published by P. Pazzi.


Gastroenterology | 1995

Postprandial Gallbladder Motor Function: Refilling and Turnover of Bile in Health and in Cholelithiasis

Riadh P. Jazrawi; P. Pazzi; M. Letizia Petroni; Napoleone Prandini; Catherine Paul; Jane Adam; S. Gullini; Tim C. Northfield

BACKGROUND & AIMS Impaired gallbladder emptying is implicated in gallstone disease. Ultrasonography and scintigraphy have shown conflicting results because the former is influenced by postprandial refilling, whereas the latter is not influenced by refilling. The aim of this study was to measure postprandial refilling and turnover of bile by combining the two techniques. METHODS Simultaneous scintigraphy and ultrasonography were used in 14 patients with gallstones and 11 healthy controls. Measurements were performed while the patients were fasting and at 10-minute intervals after a standard meal for 90 minutes, and the measurements were used to calculate postprandial refilling, turnover of bile (in milliliters), and turnover index. RESULTS Ultrasonography and scintigraphy provided different gallbladder emptying patterns. Compared with controls, patients with gallstones had impaired emptying by both scintigraphy (P < 0.0001) and ultrasonography (P < 0.01). Postprandial refilling and turnover were both reduced between 60 and 90 minutes (P < 0.05), and the turnover index was markedly reduced (1.8 vs. 3.5; P < 0.001). CONCLUSIONS Simultaneous scintigraphy and ultrasonography provide a new model of gallbladder motor function showing that refilling begins immediately postprandially. In healthy controls, the gallbladder postprandially handles up to six times its basal volume within a period of 90 minutes, but this turnover of bile is markedly reduced in cholelithiasis causing a reduced washout effect of the gallbladder contents, including cholesterol crystals.


Alimentary Pharmacology & Therapeutics | 2001

Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial

M. L. Petroni; Riadh P. Jazrawi; P. Pazzi; A. Lanzini; Massimo Zuin; M. G. Pigozzi; M. Fracchia; G. Galatola; V. Alvisi; K. W. Heaton; Mauro Podda; Tim C. Northfield

Combination therapy using ursodeoxycholic acid plus chenodeoxycholic acid has been advocated for dissolution of cholesterol gallstones because the two bile acids have complementary effects on biliary lipid metabolism and cholesterol solubilization.


Alimentary Pharmacology & Therapeutics | 2000

Review article: gall-bladder motor function in diabetes mellitus

P. Pazzi; R. Scagliarini; S. Gamberini; A. Pezzoli

Although some controversy exists, diabetic patients generally are thought to have a two‐ to threefold increased risk of cholesterol gallstones. From previous studies there is no convincing evidence for a supersaturated bile in diabetics, whereas several reports indicate that impaired gall‐bladder emptying could be one of the important factors in the increased incidence of gallstones in diabetics. However, studies of gall‐bladder motility in diabetics have yielded conflicting results, probably because of substantial heterogeneity in the patients studied, emptying stimulus and technique used to assess gall‐bladder motor function. The mechanism of the gall‐bladder emptying abnormality in diabetics is not completely understood, although it has been proposed that it could represent a manifestation of denervation caused by visceral neuropathy. Based on normal post‐prandial cholecystokinin release, it can be ruled out that impaired cholecystokinin release is the mechanism responsible for reduced gall‐bladder emptying in diabetics. Other possible explanations for impaired gall‐bladder contraction in diabetics include a decreased sensitivity of the smooth muscle of the gall‐bladder to plasma cholecystokinin, and/or decreased cholecysto‐ kinin receptors on the gall‐bladder wall.


Journal of Hepatology | 1996

Repeated bile acid therapy for the long-term management of cholesterol gallstones.

Maria L. Petroni; Riadh P. Jazrawi; Alberto Lanzini; Massimo Zuin; P. Pazzi; Mario Fracchia; Elezabetta Boga; Daniella Facchinetti; Vittorio Alvisi; Giovanni Galatola; J Martin Bland; Ken W. Heaton; Mauro Podda; Tim C. Northfield

BACKGROUND/AIMS Following non-surgical treatment, cholesterol gallstones recur in a high proportion of patients, and recurrence cannot be predicted nor effectively prevented. Our aim was to test prospectively the viability and the efficacy of repeated bile acid therapy, in which recurrent stones are diagnosed at an early stage by regular ultrasound monitoring and promptly retreated, as a strategy for the management of these patients in clinical practice. METHODS One hundred and seventy-two consecutive patients were recruited upon achieving complete gallstone dissolution using non-surgical therapy (bile acids or lithotripsy plus bile acids), and followed up at 6-monthly intervals by ultrasound scan. Gallstone recurrence was promptly treated by a combination of ursodeoxycholic acid plus chenodeoxycholic acid (5 mg/kg per day each) for a period of 2 years, or less if complete redissolution was achieved. Median follow-up period was 34 months (range 6-70). RESULTS Forty-five patients had gallstone recurrence; of these, 39 underwent one or more repeated courses of bile acid therapy (follow-up data available in 27). Gallstone recurrence rate was 15% at 1 year and 47% at 5 years. Average annual redissolution rate of recurrent gallstones (intention to treat) was 41%. The proportion of gallstone-free patients in the whole population was 88%, 84%, 77%, 78%, 75% at 1-5 years, respectively, and rose to > 90% at 3 years onwards in patients with single primary stones. CONCLUSIONS We conclude that repeated bile acid therapy maintains the majority of patients gallstone free, and is therefore an effective long-term management strategy, especially in patients with primary single gallstones.


Alimentary Pharmacology & Therapeutics | 1996

High effectiveness and safety of one‐week antibiotic regimen in Helicobacter pylori eradication

M. Dalla Libera; P. Pazzi; Giuliano Carli; S. Gamberini; R. Scagliarini; Alberto Merighi; S. Gullini

Background: Helicobacter pylori is strongly associated with peptic ulcer: H. pylori eradication markedly decreases the recurrence rate of duodenal and gastric ulcer, but the optimum length of antibiotic therapy in the eradication of H. pylori is still unclear.


The American Journal of Gastroenterology | 1998

Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study

P. Pazzi; R. Scagliarini; Davide Sighinolfi; Marcello Govoni; Renato La Corte; Sergio Gullini

Objectives:Conflicting results on the relationship between gallstone disease and the use of nonsteroidal antiinflammatory drugs (NSAIDs) have been reported, but studies on the effect of NSAID use in populations not selected on the basis of a high risk for gallstone development are still lacking.Methods:We conducted a case-control study involving 216 patients, regular NSAID users (43 men and 173 women) consecutively admitted to a rheumatology department, suffering from rheumatoid arthritis (n = 147), osteoarthritis (n = 49), and ankylosing spondylitis (n = 20). Two-hundred sixteen patients who were not NSAID users, matched for gender, age, and body mass index, consecutively admitted to a medical department for various medical pathologies, acted as a control group. All patients underwent upper abdomen ultrasonography.Results:The overall prevalence of gallstones was similar in the two groups: 24.0% in NSAID users (15.7% actual stones and 8.3% previous cholecystectomy) and 21.3% in controls (13.9% gallstones and 7.4% cholecystectomy). The prevalence of gallstone disease was significantly higher in women than in men, and the mean age was higher in gallstone patients than in gallstone-free patients, in both groups. No significant differences in type and duration of arthritis condition, type and dose of NSAID taken, and duration of treatment between gallstone patients and gallstone-free patients were found. On logistic regression analysis only female gender, aging, and family history of gallstone disease were significantly associated with the presence of gallstones, whereas no relationship between NSAID use and gallstone disease was found.Conclusions:Chronic NSAID ingestion does not seem to prevent gallstones in arthritis patients; in these patients gallstone disease is associated with classic risk factors (female gender and age).


Clinical Rheumatology | 1996

Colon involvement in systemic sclerosis: Clinical-radiological correlations

Marcello Govoni; M. Muccinelli; P. Panicali; R. La Corte; P. Nuccio Scutellari; Carlo Orzincolo; P. Pazzi; Francesco Trotta

SummaryAbout one third of all patients with systemic sclerosis (SS) presents colon abnormalities, although these may be underestimated because they frequently remain asymptomatic for a long time. Thirty-five patients (33 women and 2 men; mean age 56.5 years; mean disease duration 11.9 years) affected by SS (25 with limited and 10 with diffuse pattern of skin involvement) were investigated using barium enema to detect radiological changes in the colon, and to correlate them with other visceral involvement, autoantibody profile, abdominal symptoms and duration of the disease. Ten patients (28.6%) showed X-rays abnormalities (excluding isolated diverticula), wide-mouthed sacculations being the most frequent finding. Our data confirm that the colon is frequently involved in SS, even in the limited form of the disease. The most relevant finding was the dissociation between clinical symptoms and radiological features which proved to be more evident among the patients with limited SS. No correlations were found between the radiological picture and any other parameter, thus suggesting that careful evaluation of the colon should be performed in any patient suffering from the disease.


The American Journal of Gastroenterology | 1989

Patterns of physical modes of contact between Campylobacter pylori and gastric epithelium: implications about the bacterial pathogenicity.

Michele Caselli; Lucio Trevisani; P. Pazzi; Guglielmetti P; Bovolenta Mr; Stabellini G


Gastroenterology | 1995

Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

F. Bazzoli; S. Gullini; R.M. Zagari; P. Pazzi; M.Dalla Libera; P. Pozzato; S. Sottill; S. Fossi; Giuliano Carli; R. Scagliarini; P. Simoni; E. Roda


Gut | 1990

Diabetes and cholelithiasis.

P. Pazzi; L Trevisani; S Sartori; D Sighinolfi; Vittorio Alvisi

Collaboration


Dive into the P. Pazzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge